(PharmaNewsWire.Com, February 26, 2018 ) Middle East and Africa Genomics Market was worth USD 818.4 million in 2017 and estimated to be growing at a CAGR of 8.9%, to reach USD 1.25 billion by 2022. Genomics is a discipline which analyzes the function and structure of genomes. It uses various sampling, sequencing, and data analysis and interpretation techniques to decode, assemble, and analyze genomes. The knowledge of complete set of DNA helps to identify certain genetic diseases, develop best course of treatment, and contribute to precision medicine.
The genomics market is chiefly driven by the intensifying level of competition in the global pharmaceutical industry and the increased use of genomics in research and development of new drug classes. An increased demand for genetically modified animals and plants and the constantly reducing prices of genetic procedures are also leading to significant developments in the global genomics market through a rising scope for research and innovation. However, the high cost of genomic instruments is one of the major restraints of the market.
The report segments the market based on product, technology, process, application and end user. The various product segments of the genomics market include instruments/systems, consumables, and services. The consumables segment is expected to account for the largest share of the genomics market. This is attributed to factors such as repeated usage of consumables for the genomic experiments, increasing research programs by academic institutes and non-profit organizations. The market by technology is segmented into Sequencing, Microarray technology, PCR, Nucleic acid extraction and other technologies. Based on the various application areas of genomics, the report segments the market into diagnostics, drug discovery & development, personalized medicine, and agriculture & animal research, among others. The market by process is segmented into the library preparation, sequencing & imaging, and data analysis. Based on the end users the genomics market is segmented into research centres, academic institutes, & government institutes; hospitals & clinics; and pharmaceutical & biotechnology companies, among others. The research centres, academic institutes, and government institutes segment accounted for the largest share of the market, by end user. This largest share is attributed to the increasing research initiatives and projects in the area of genomics worldwide. On the basis of geography, the market is analysed under various regions namely Middle East and Africa.
Some of the key players in this market include Affymetrix, Inc., Agilent Technologies, BGI, Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., Qiagen, Roche Diagnostics, Life Technologies, Cepheid.
About Market Data Forecast Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: